Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh
· Delayed Price · Currency is BDT 32.60
+1.70 (5.50%)
At close: Feb 27, 2025
Orion Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | -16 | 318.12 | 640.94 | 846.08 | 939.06 | 665.69 | Upgrade
|
| Depreciation & Amortization | 336.32 | 588.7 | 601.12 | 498.45 | 1,019 | 936.82 | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.86 | 2.86 | -0.21 | -0.08 | 5.93 | 0.05 | Upgrade
|
| Other Operating Activities | 1,389 | 432.84 | 256.66 | -225.31 | 528.16 | 857.53 | Upgrade
|
| Change in Accounts Receivable | 1,319 | 1,319 | 1,004 | -2,841 | -1,448 | -978.16 | Upgrade
|
| Change in Inventory | -96.04 | -96.04 | 45.45 | -263.32 | -133.11 | -359.57 | Upgrade
|
| Change in Accounts Payable | -1,134 | -1,134 | -327.19 | 3,226 | 1,603 | 1,010 | Upgrade
|
| Change in Other Net Operating Assets | 155.36 | 155.36 | 272.12 | -79.3 | 77.52 | -250.21 | Upgrade
|
| Operating Cash Flow | 1,956 | 1,587 | 2,493 | 1,162 | 2,592 | 1,882 | Upgrade
|
| Operating Cash Flow Growth | 8.36% | -36.36% | 114.60% | -55.17% | 37.68% | 29.95% | Upgrade
|
| Capital Expenditures | -2,031 | -1,876 | -3,859 | -2,667 | -4,277 | -1,543 | Upgrade
|
| Sale of Property, Plant & Equipment | 371.11 | 371.11 | - | - | - | 5.8 | Upgrade
|
| Cash Acquisitions | 39.41 | 445.66 | -1,376 | -379.31 | -1,633 | 89.97 | Upgrade
|
| Investment in Securities | -0.22 | -0.22 | 0.01 | -8.6 | 0.03 | -7.42 | Upgrade
|
| Other Investing Activities | 18.57 | 24.06 | 27.28 | 19.68 | 45.44 | 36.4 | Upgrade
|
| Investing Cash Flow | -1,602 | -1,035 | -5,208 | -3,035 | -5,864 | -1,419 | Upgrade
|
| Short-Term Debt Issued | - | 16.21 | 11.2 | 387.98 | 392.27 | - | Upgrade
|
| Long-Term Debt Issued | - | 632.52 | 3,311 | 1,784 | 3,131 | 4,960 | Upgrade
|
| Total Debt Issued | -935.88 | 648.73 | 3,322 | 2,172 | 3,523 | 4,960 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -3,009 | Upgrade
|
| Long-Term Debt Repaid | - | -22.33 | -28.36 | -33.66 | -40.63 | -34.54 | Upgrade
|
| Total Debt Repaid | 1,814 | -22.33 | -28.36 | -33.66 | -40.63 | -3,043 | Upgrade
|
| Net Debt Issued (Repaid) | 878.3 | 626.4 | 3,293 | 2,138 | 3,482 | 1,917 | Upgrade
|
| Common Dividends Paid | -269.89 | -269.9 | -152.94 | -324.54 | -340.17 | -373.06 | Upgrade
|
| Dividends Paid | -269.89 | -269.9 | -152.94 | -324.54 | -340.17 | -373.06 | Upgrade
|
| Other Financing Activities | -999.31 | -890.42 | -401.76 | -249.56 | -488.68 | -1,065 | Upgrade
|
| Financing Cash Flow | -390.89 | -533.93 | 2,739 | 1,564 | 2,654 | 478.37 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | -0 | 0 | -0 | - | Upgrade
|
| Net Cash Flow | -36.97 | 17.62 | 23.97 | -308.86 | -619.18 | 941.99 | Upgrade
|
| Free Cash Flow | -74.94 | -289.06 | -1,366 | -1,505 | -1,685 | 338.88 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 238.57% | Upgrade
|
| Free Cash Flow Margin | -1.02% | -2.72% | -9.81% | -15.58% | -15.56% | 4.43% | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -1.24 | -5.84 | -6.43 | -7.20 | 1.45 | Upgrade
|
| Cash Interest Paid | 1,023 | 890.42 | 401.76 | 249.56 | 488.68 | 1,065 | Upgrade
|
| Cash Income Tax Paid | 102.44 | 194.54 | 117.03 | 95.73 | 40.91 | 36.47 | Upgrade
|
| Levered Free Cash Flow | -692.44 | 15.92 | -3,066 | -1,366 | -36.58 | -4,219 | Upgrade
|
| Unlevered Free Cash Flow | -364 | 261.78 | -2,974 | -1,257 | 103.06 | -3,771 | Upgrade
|
| Change in Net Working Capital | -915.87 | -968.07 | 336.03 | -489.01 | -2,400 | 4,134 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.